ロード中...
Rationale for the Advancement of PI3K Pathway Inhibitors for Personalized Chordoma Therapy
PURPOSE: Chordomas are rare and serious tumors with few effective treatments outside of aggressive surgery and radiation. Targeted therapies may present a more effective option for a subset of patients with lesions possessing certain genetic biomarkers. METHODS: A small molecule inhibitor library wa...
保存先:
| 出版年: | J Neurooncol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7474463/ https://ncbi.nlm.nih.gov/pubmed/32067197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11060-020-03418-7 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|